Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM
Open Access
- 23 March 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14
Abstract
Objective: The aim of this study was to systematically explore the pyrrolizidine alkaloids (PAs) type, content and risk assessment in the three Boraginaceae used in TCM, involving Arnebia euchroma (AE), A. guttata (AG), and Lithospermum erythrorhizon (LE).Method: A UHPLC–MS/MS method was established to simultaneously determine eight pyrrolizidine alkaloids (PAs), namely intermedine, lycopsamine, intermedine N-oxide, lycopsamine N-oxide, 7-acetyllycopsamine, 7-acetyllycopsamine N-oxide, echimidine N-oxide, and echimidine in the three herbs. Based on these results, the risk assessment was explored using the routine margin of exposure (MOE) combined with relative potency (REP) for oral and external usage, respectively.Results and Conclusion: Imermedine and imermedine N-oxide were common components in the eight tested PAs. 7-acetyllycopsamine and its N-oxide were not detected in AE; echimidine and its N-oxide were not detected in AG; lycopsamine and its N-oxide, 7-acetyllycopsamine and its N-oxide were not detected in LE. The total contents of 8 PAs in 11 batches of AG was341.56–519.51 μg/g; the content in 15 batches of LE was 71.16–515.73 μg/g, and the content in 11 batches of AE was 23.35–207.13 μg/g. Based on these results, the risk assessment was explored using MOE combined with REP for oral and external usage, respectively. The findings of the risk assessment method of PAs based on MOE combined with the REP factor were consistent with the clinical toxicity results. As an oral herb, AE had low risk or no risk due to its low PA contents, and individual batches of LE were medium risk, while attention should be paid to their clinical use.AG was also low risk. The external use of the three Boraginaceae used in TCM was not associated with any risk. This study systematically explored the PA type and content of the three Boraginaceae used in TCM. Additionally, the refined risk assessment of PAs based on REP provided a more scientific basis for quality evaluation and rational use of the medicinal Boraginaceae used in TCM to improve public health.Keywords
This publication has 23 references indexed in Scilit:
- Risks for human health related to the presence of pyrrolizidine alkaloids in honey, tea, herbal infusions and food supplementsEFSA Journal, 2017
- Comparative HILIC/ESI-QTOF-MS and HPTLC studies of pyrrolizidine alkaloids in flowers of Tussilago farfara and roots of Arnebia euchromaPhytochemistry Letters, 2017
- Interim relative potency factors for the toxicological risk assessment of pyrrolizidine alkaloids in food and herbal medicinesToxicology Letters, 2016
- Acute and 28-Day Subacute Toxicity Studies of Hexane Extracts of the Roots of Lithospermum erythrorhizon in Sprague-Dawley RatsToxicological Research, 2015
- Detection of glucocorticoid receptor agonists in effluents from sewage treatment plants in JapanScience of The Total Environment, 2015
- Single- and Repeat-dose Oral Toxicity Studies of Lithospermum erythrorhizon Extract in DogsToxicological Research, 2015
- Application of the equivalency factor concept to the phototoxicity and –genotoxicity of furocoumarin mixturesFood and Chemical Toxicology, 2014
- Diversity of Pyrrolizidine Alkaloids in the Boraginaceae Structures, Distribution, and Biological PropertiesDiversity, 2014
- The 2005 World Health Organization Reevaluation of Human and Mammalian Toxic Equivalency Factors for Dioxins and Dioxin-Like CompoundsToxicological Sciences, 2006
- Pyrrolizidine alkaloids from Lithospermum erythrorhizonPhytochemistry, 1990